The QUELIMMUNE ® (SCD-PED) therapy is being commercialized for children with AKI and sepsis or septic condition weighing 10 kilograms or more who are on antibiotics and being treated in the ICU with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results